PFPG
GMAB icon

Pinnacle Financial Partners (Georgia)’s Genmab GMAB Stock Holding History

Pinnacle Financial Partners (Georgia)’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31M Buy
47,573
+132
+0.3% +$3.51K 0.01% 580
2026
Q1 		$1.27M Buy
47,441
+126
+0.3% +$3.78K 0.01% 547
2025
Q4 		$1.46M Buy
+47,315
New +$1.47M 0.01% 525

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Pinnacle Financial Partners (Georgia)'s GMAB Position: Q2 2026 in Review

Pinnacle Financial Partners (Georgia) increased its Genmab (GMAB) stake by 0.28% in Q2 2026, buying an estimated $3.51K and bringing the position to 47,573 shares worth $1.31M. The position accounts for 0.01% of the portfolio, ranked #580.

Pinnacle Financial Partners (Georgia) first reported a position in GMAB in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.46M in Q4 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Pinnacle Financial Partners (Georgia) held 47,573 shares of Genmab worth $1.31M as of Q2 2026.
  • Pinnacle Financial Partners (Georgia) bought 132 Genmab shares in Q2 2026, an estimated $3.51K.
  • Genmab made up 0.01% of Pinnacle Financial Partners (Georgia)'s portfolio in Q2 2026, its #580 holding.
  • Pinnacle Financial Partners (Georgia) first reported a position in Genmab in Q4 2025 and has held it in 3 quarters since.
  • Pinnacle Financial Partners (Georgia)'s Genmab position peaked at $1.46M in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Pinnacle Financial Partners (Georgia)'s 13F filing for Q2 2026, filed 14 Aug 2026.